Please login to the form below

Not currently logged in
Email:
Password:

bribery

This page shows the latest bribery news and features for those working in and with pharma, biotech and healthcare.

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

This conduct consists of a complex, multipart scheme involving monopoly, bribery, racketeering, fraud and other deceptive and unfair practices.”. ... Finally, Humana alleges Mallinckrodt maintained the artificially inflated demand “through a

Latest news

More from news
Approximately 15 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    One of the most serious concerns is bribery, corruption and fraud, well-known problems in the country in recent times. ... So how does AZ ensure it doesn’t get entangled in bribery or corruption in China?

  • Risky business for pharma Risky business for pharma

    to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... posing the most significant risks overall”, perhaps due to continued

  • Stress testing for the perfect compliance storm Stress testing for the perfect compliance storm

    Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... However, EY’s Global Fraud Survey 2016 shows 11% of company

  • Harnessing commercial innovation Harnessing commercial innovation

    However, the situation in China was about to change significantly. Christian took up his China Region post in August 2013, when the full ramifications of the bribery scandal at GlaxoSmithKline had

  • The Heart of the Matter 5 - the only way is ethics The Heart of the Matter 5 - the only way is ethics

    The strengthening of international regulations around anti-bribery – and renewed vigour in their enforcement – has placed pharmaceutical companies under unparalleled scrutiny.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics